Patents

[1] Master Adam. Nucleic acid molecule designed for selective enhancement of protein synthesis. Patent no. PL237080B1 (P.393170, Pat.237080), International classification: C12N 15/113, Submission date: 12/04/2010, Publication date: 10/21/2020. Documents: BUP no: 13/2012, WUP no.: 05/2021 section P001, Publisher: Patent Office of the Republic of Poland. Espacenet link, BUP link, WUP link, Google patents link (ctrl + click the link). Additional information: A novel method for gene-specific enhancement of protein translation was used for the first time in this patent to generate a set of patented oligonucleotides designed to enhance translation of selected proteins. This method was successfully replicated in research on tumor suppressor genes, as reported by Master et al. (2016, CMKP, Warsaw) link. It has also been cited and used as a reference in Roche's patent WO2023111337A1 (2023) and cited by Ionis Pharmaceuticals’ patent EP3313989B1 (2024) on Google Patents. This demonstrates that the method discovered by Adam Master (see project no.: Dz.3.4/ML/2/05, ZPORR) is gaining international recognition, as reported in a patent attorney's opinion on the novelty of the concept of invention PL237080B1 link.

[2] Master Adam, Skrzypczak Magdalena, Master Aneta, Nowacka Joanna, Plucienniczak Andrzej, Wroblewska Sylwia. Oligonucleotide and polynucleotide for the detecting and determining mutation, particularly hereditary mutation in the p53 human gene, method for the manufacture of this polynuclotide and method and the apparatus for the detecting and determining mutation. Patent no: PL373443A1. International classification: C12N15/10; C12P19/30; C12Q1/68; C12P35/00. Application number: PL20050373443 20050307. Publication date: 09/18/2006. Documents: BUP no: 19/2006, WUP no. 05/2012, P010. Publisher: Patent Office of the Republic of Poland. Espacenet link, UP link

[3] Master Adam, Skrzypczak Magdalena, Master Aneta, Nowacka Joanna, Plucienniczak Andrzej, Wroblewska Sylwia. Oligonucleotide and polynucleotide for the detecting and determining mutation, particularly hereditary mutation in the human genes BRCA1 and BRCA2, method for the manufacture of this polynuclotide and method and the apparatus for the detecting and determining mutation in the human genes BRCA1 and BRCA2. Patent number: PL373442 (A1). International classification: C12N15/10; C12P19/30; C12N15/07; C12N15/11; A61P35/00. Application number: PL20050373442 20050307. Publication date: 09/18/2006. Documents: BUP no: 19/2006, WUP no. 05/2012, P010. Publisher: Patent Office of the Republic of Poland. Espacenet link, UP link

[4] Master Adam, Skrzypczak Magdalena (authors). Oligonucleotide, its application and method and apparatus designed for detection of gondiae DNA Toxoplasma gonidii. Patent number: PL358894 (A1). International classification: C07K14/45; C12Q1/68; C12P19/34; A61P33/02; C12N15/30. Application number: PL20030358894 20030226 . Documents: BUP no: 18/2004, WUP no: 06/2009, P001. Publication date: 09/06/2004. Publisher: Patent Office of the Republic of Poland. Espacenet Link, UP link

Click the link to see more information.

External patents citing my publications (Lens.org)

External patents (Lens.org) citing my publication no. e0155359

Patent: US 11414657 B2, Modified CRISPR RNA and modified single CRISPR RNA and uses thereof.
Patent: WO 2023/111337 A1, Antisense oligonucleotides,that used similar method described for the first time in my patent PL237080B1,

INVENTIONS

SCIENTIFIC INTERESTS

PUBLICATIONS

RESEARCH

Curriculum Vitae

Page updated

Google Sites

Report abuse